MARY BOYCE: Open Payments
NPI 1427336817 · QUEENSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 30 payments from 14 companies in 2025. Trend: 2023 $467 · 2024 $312 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $153 |
| Novo Nordisk Inc | 6 | $123 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Astellas Pharma US Inc | 2 | $51 |
| ABBVIE INC. | 2 | $29 |
| Dexcom, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
Products named: NURTEC ODT, Wegovy, GARDASIL 9, Veozah, PREVNAR 20, VRAYLAR, Dexcom G6 Transmitter, ELIQUIS.
Industry payments across MD — which companies pay providers there.
